Valneva SE (VALN) Revenue (2021 - 2026)
Valneva SE (VALN) reported Revenue of $35.7 million for Q1 2026, down 30.11% on a YoY basis from $51.1 million in Q1 2025, and down 20.28% sequentially from $44.8 million in Q4 2025.
Valneva SE (VALN) Revenue (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has 6 years of Revenue data on file, last reported at $35.7 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue fell 30.11% year-over-year to $35.7 million; the trailing twelve-month figure through Mar 2026 stood at $161.7 million (down 16.14% YoY), and the FY2025 full-year result was $183.8 million, up 3.99% from the prior year.
- Revenue fell to $35.7 million in Q1 2026, from $44.8 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $292.7 million in Q4 2022 to a low of $18.1 million in Q1 2022.
- A 5-year average of $54.5 million and a median of $40.9 million in 2023 frame the typical range for Revenue.
- Across the five-year window, Revenue soared 1360.78% in 2022 and slumped 82.51% in 2023, its largest moves.
- Tracing VALN's Revenue over 5 years: stood at $292.7 million in 2022, then tumbled by 82.51% to $51.2 million in 2023, then rose by 6.03% to $54.3 million in 2024, then declined by 17.44% to $44.8 million in 2025, then retreated by 20.28% to $35.7 million in 2026.
- Business Quant data shows VALN's Revenue at $35.7 million in Q1 2026, $44.8 million in Q4 2025, and $33.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Valneva SE | 811.46 Mn | 688.23 Mn | 5.08 Mn | 35.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.73 Mn |
| Dec 31, 2025 | 44.82 Mn |
| Sep 30, 2025 | 33.18 Mn |
| Jun 30, 2025 | 48.02 Mn |
| Mar 31, 2025 | 51.12 Mn |
| Dec 31, 2024 | 54.28 Mn |
| Sep 30, 2024 | 48.56 Mn |
| Jun 30, 2024 | 38.91 Mn |
| Mar 31, 2024 | 34.93 Mn |
| Dec 31, 2023 | 51.20 Mn |
| Sep 30, 2023 | 39.70 Mn |
| Jun 30, 2023 | 40.91 Mn |
| Mar 31, 2023 | 34.45 Mn |
| Dec 31, 2022 | 292.69 Mn |
| Sep 30, 2022 | 41.43 Mn |
| Jun 30, 2022 | 18.32 Mn |
| Mar 31, 2022 | 18.14 Mn |
| Dec 31, 2021 | 20.04 Mn |
| Sep 30, 2021 | 16.16 Mn |
| Jun 30, 2021 | 18.83 Mn |